| Literature DB >> 35281566 |
Xuelong Huang1, Ning Lan1, Yanfeng Zhang1, Wei Zeng1, Haifeng He2, Xiuhong Liu2.
Abstract
Photoacoustic (PA) imaging has received more and more attention on disease diagnosis and fundamental scientific research. It is still challenging to amplify their imaging ability and reduce the toxicity of inorganic materials and exogenous contrast agents. Semiconducting polymer nanoparticles (SPNs), as a new type of contrast agent, have the advantages of low toxicity, flexible structure adjustment, good photostability, and excellent photothermal conversion efficiency. SPNs containing benzo(1,2-c;4,5-c')bis(1,2,5)thiadiazole (BBT) units, as the most classic second near-infrared window (NIR-II, 1,000-1700 nm) PA contrast agents, can achieve light absorption in the NIR-II region, thereby effectively reducing light loss in biological tissues and improving imaging resolution. This mini review summarizes the recent advances in the design strategy of BBT and its derivative-based semiconducting polymer nanoparticles for second near-infrared photoacoustic imaging. The evolution process of BBT blocks provides a unique perspective for the design of high-performance NIR-II PA contrast agents.Entities:
Keywords: benzobisthiadiazole; nanoparticles; near-infrared-II; photoacoustic imaging; semiconducting polymer; thiadiazolobenzotriazole; thiadiazoloquinoxaline
Year: 2022 PMID: 35281566 PMCID: PMC8907825 DOI: 10.3389/fchem.2022.842712
Source DB: PubMed Journal: Front Chem ISSN: 2296-2646 Impact factor: 5.221
SCHEME 1Chemical structures of BBT, TBZ, and ATQ-based SPs for NIR-II PA imaging.
Summary of the properties and applications of representative NIR-II SPNs discussed in this review (λonset, the onset of absorption value; λmax, the absorption peak value; Ex, excitation wavelength; η, the photothermal conversion efficiency; and NA, not applicable).
| SPNs | λonset (nm) | λmax (nm) | Ex (nm) | Properties | Disease model | References |
|---|---|---|---|---|---|---|
| P-BBT-1 | 1,320 | 1,079 | 1,064 | SBR = 2.3 | Brain |
|
|
| ||||||
| P-BBT-2 | 1,280 | 1,064 | 1,064 | SBR = 90 | Brain tumor |
|
| P-BBT-3 | 1,230 | 1,079 | 1,064 |
| Brain |
|
| P-BBT-4 | 1,280 | 1,064 | 1,064 | SBR = 59 | Orthotopic brain tumor |
|
| P-BBT-5 | 1700 | 1,150 | 1,064 |
| HepG-2 tumor cells |
|
| P-BBT-6 | 1900 | 1,079 | 1,064 |
| Brain |
|
| P-BBT-7 | >1,500 nm | 1,300 | 1,064 |
| Breast tissue |
|
| P-TBZ-1 | 1,400 | 1,064 | 1,064 | Imaging depth = 4 cm (breast tissue), 3.8 mm (skull) | Breast tissue/brain tumor |
|
| P-TBZ-2 | 1,450 | 1,170 | 1,064 | SBR = 22.3 dB; depth = 1,001 µm | Cerebral/tumor vasculatures |
|
| P-TBZ-3 | 1,400 | 1,064 | 1,064 |
| Tumor-bearing mice |
|
| P-ATQ-1 | 1,200 | 929 | 1,064 |
| Brain tumor |
|
| P-ATQ-2 | 1,130 | 990 | 1,064 | Contrast enhancement = 21.7-fold | Subcutaneous/brain |
|
| P-ATQ-3 | 1,150 | 897 | 1,064 | NA | Situ hepatic tumor |
|
| P-ATQ-4 | 1,200 | 905 | 1,064 | NA | Situ hepatic tumor |
|
| P-ATQ-5 | 1,380 | 1,109 | 1,064 |
| Situ hepatic tumor |
|
| P-ATQ-6 | 1,550 | 1,140 | 1,064 | NA | Brain vasculature |
|
| P-ATQ-7 | 2000 | 1,270 | 1,064 | Depth = 10 mm | Brain vasculature |
|
| P-ATQ-8 | 2,214 | 1,500 | 1,064 | NA | Brain vasculature |
|
| P-ATQ-9 | NA | 1,253 | 1,064 | Depth = 3 cm | Brain vasculature |
|
| P-ATQ-10 | 1,060 | 930 | 980 | Small vessels = ∼2 μm | The whole body |
|
| P-ATQ-11 | 1,350 | 1,000 | 1,064 |
| Breast tissue |
|